MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway FactorsJayavarshni Ganesan, Stefan Engelhardt, Deepak Ramanujam et al.|Circulation|2013Cited by 242
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytesClaudia Jentzsch, Stefan Engelhardt, Simon Leierseder et al.|Journal of Molecular and Cellular Cardiology|2011Cited by 116
MiR-223 is dispensable for platelet production and function in miceSimon Leierseder, Stefan Engelhardt, Tobias Petzold et al.|Thrombosis and Haemostasis|2013Cited by 37
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Florian Kuchenbauer, Nicole Pochert et al.|Experimental Hematology|2015Cited by 34
Preferential microRNA targeting revealed by in vivo competitive binding and differential Argonaute immunoprecipitationStanislas Werfel, Stefan Engelhardt, Simon Leierseder et al.|Nucleic Acids Research|2017Cited by 24